BackAlibaba Health Information Technology Limited Overview

Alibaba Health Information Technology Limited Goodwill

Latest goodwill for ALBBY: $800M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$802.33M
1.05% YoYΔ $-8.52M vs prior year quarter

Peer average

Loading

Alibaba Health Information Technology Limited Goodwill History

Loading

Alibaba Health Information Technology Limited vs. peers: Goodwill Comparison

Loading

Alibaba Health Information Technology Limited Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alibaba Health Information Technology Limited (ALBBY) FAQ

Alibaba Health Information Technology Limited's goodwill stands at $800M as of March 2026. That compares with $810M in the prior-year period — down 1.1% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Alibaba Health Information Technology Limited reported $800M in goodwill versus $810M a year earlier — a 1.1% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $810M in the prior-year period — down 1.1% year over year. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Alibaba Health Information Technology Limited's goodwill evolved across reporting periods, while the comparison chart places ALBBY next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, goodwill is commonly used to spot outliers. Alibaba Health Information Technology Limited's reading of $800M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.